QT
Quantbot Technologies Portfolio holdings
AUM
$3.9B
1-Year Return
6.06%
This Quarter Return
+4.91%
1 Year Return
+6.06%
3 Year Return
+15.52%
5 Year Return
+20.93%
10 Year Return
+4.18%
AUM
$1.27B
AUM Growth
+$221M
(+21%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
15.17%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
2,064
New
700
Increased
360
Reduced
340
Closed
648
Top Buys
| 1 |
IQVIA
IQV
|
+$13.2M |
| 2 |
Walmart
WMT
|
+$12.8M |
| 3 |
Ecolab
ECL
|
+$12.6M |
| 4 |
Prologis
PLD
|
+$11.1M |
| 5 |
MetLife
MET
|
+$10.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.2M |
| 2 |
Morgan Stanley
MS
|
+$11.9M |
| 3 |
Comcast
CMCSA
|
+$10.4M |
| 4 |
Microsoft
MSFT
|
+$8.78M |
| 5 |
CERN
Cerner Corp
CERN
|
+$8.71M |
Sector Composition
| 1 | Technology | 16.95% |
| 2 | Consumer Discretionary | 14.35% |
| 3 | Industrials | 12.9% |
| 4 | Healthcare | 11% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Mine Safety
MSA
$6.63B
| $16K | ﹤0.01% |
100
-479
| -83% | -$76.6K |
|
1252
Rekor Systems
REKR
$152M
| $16K | ﹤0.01% |
+1,592
| New | +$16K |
|
1253
Ryvyl
RVYL
$9.53M
| $16K | ﹤0.01% |
+140
| New | +$16K |
|
1254
Voyager Therapeutics
VYGR
$232M
| $16K | ﹤0.01% |
4,049
-11,006
| -73% | -$43.5K |
|
|
YQ
1255
17 Education & Technology Group
YQ
$23.7M
| $16K | ﹤0.01% |
222
-139
| -39% | -$10K |
|
|
AZRE
1256
DELISTED
Azure Power Global Limited
AZRE
| $16K | ﹤0.01% |
+600
| New | +$16K |
|
|
DOC
1257
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $16K | ﹤0.01% |
900
-934
| -51% | -$16.6K |
|
1258
Camtek
CAMT
$3.98B
| $15K | ﹤0.01% |
+400
| New | +$15K |
|
1259
CSG Systems International
CSGS
$1.86B
| $15K | ﹤0.01% |
334
-621
| -65% | -$27.9K |
|
1260
SI-BONE Inc
SIBN
$677M
| $15K | ﹤0.01% |
+500
| New | +$15K |
|
1261
S&T Bancorp
STBA
$1.5B
| $15K | ﹤0.01% |
500
-200
| -29% | -$6K |
|
1262
Stewart Information Services
STC
$2.09B
| $15K | ﹤0.01% |
273
+19
| +7% | +$1.04K |
|
|
ACB
1263
Aurora Cannabis
ACB
$274M
| $14K | ﹤0.01% |
+160
| New | +$14K |
|
1264
Akero Therapeutics
AKRO
$3.48B
| $14K | ﹤0.01% |
600
+400
| +200% | +$9.33K |
|
1265
Corcept Therapeutics
CORT
$7.68B
| $14K | ﹤0.01% |
+666
| New | +$14K |
|
1266
First Financial Bancorp
FFBC
$2.46B
| $14K | ﹤0.01% |
623
+399
| +178% | +$8.97K |
|
1267
Finance of America Companies
FOA
$278M
| $14K | ﹤0.01% |
+195
| New | +$14K |
|
1268
Ichor Holdings
ICHR
$579M
| $14K | ﹤0.01% |
+276
| New | +$14K |
|
1269
LifeMD
LFMD
$275M
| $14K | ﹤0.01% |
1,272
+487
| +62% | +$5.36K |
|
1270
Quantum-Si Incorporated
QSI
$239M
| $14K | ﹤0.01% |
+1,200
| New | +$14K |
|
1271
Telefônica Brasil
VIV
$20B
| $14K | ﹤0.01% |
1,678
-4,851
| -74% | -$40.5K |
|
|
JNCE
1272
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14K | ﹤0.01% |
2,161
+1,800
| +499% | +$11.7K |
|
1273
Archrock
AROC
$4.29B
| $13K | ﹤0.01% |
1,500
-82,235
| -98% | -$713K |
|
1274
Conduent
CNDT
$445M
| $13K | ﹤0.01% |
1,829
-32,490
| -95% | -$231K |
|
1275
Crinetics Pharmaceuticals
CRNX
$3.2B
| $13K | ﹤0.01% |
+700
| New | +$13K |
|